Abstracts - faqs.org

Abstracts

Business, international

Search abstracts:
Abstracts » Business, international

ICN's U.S. suit hits Yugoslav, Serb leaders

Article Abstract:

United States-based ICN Pharmaceuticals Inc., has filed a lawsuit against Serbia and Yugoslav state governments for nationalising its subsidiary ICN Yugoslavia. ICN Pharmaceuticals seeks $500 million for the forcible acquisition.

Comment:

ICN Pharmaceutical Inc., sues Serbia and Yugoslav government for nationalizing its subsidiary ICN Yugoslavia.

Author: Reed, John (American senator)
Publisher: Dow Jones Publishing Co. (Europe)
Publication Name: Wall Street Journal. Europe
Subject: Business, international
ISSN: 0921-9986
Year: 1999
Pharmaceutical Preparation Manufacturing, Pharmaceutical preparations, Cases, Laws, regulations and rules, Economic policy, Yugoslavia, ICN, Government ownership, Nationalization, Serbia, Valeant Pharmaceuticals International, ICN Yugoslavia

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Amgen plans to buy Immunex for $16 billion in cash, stock

Article Abstract:

Amgen Inc. has reached a deal to acquire Immunex Corp. in a deal valued at $16 billion. The deal, one of the largest biotechnology acquisitions ever, will be conducted in cash and shares.

Author: Hamilton, David P.
Publisher: Dow Jones Publishing Co. (Europe)
Publication Name: Wall Street Journal. Europe
Subject: Business, international
ISSN: 0921-9986
Year: 2001
Amgen Inc., Immunex Corp., AMGN, IMNX

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Bristol-Myers nears pact to buy ImClone stake

Article Abstract:

Bristol-Myers Squibb Co. is close to a deal in which it will acquire a minority share in ImClone Systems Inc. Bristol-Myers will acquire 19.9% of ImClone for $1 billion.

Publisher: Dow Jones Publishing Co. (Europe)
Publication Name: Wall Street Journal. Europe
Subject: Business, international
ISSN: 0921-9986
Year: 2001
In-Vitro Diagnostic Substance Manufacturing, Diagnostic substances, Diagnostic Reagents, Bristol-Myers Squibb Co., BMY, ImClone Systems Inc., Diagnostic reagents industry, IMCL

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Subjects list: United States, Pharmaceutical industry, Mergers, acquisitions and divestments, Drugs
Similar abstracts:
  • Abstracts: Sex, swagger helped fallen Gucci recover its glamour. Apax nears deal to buy Hilfiger for $1.5 billion. Executives sell another affiliate to Tommy Hilfiger
  • Abstracts: Danone's Polish unit recalls dessert. Poland to open license tender for phone service. Pawnshops are windows to Poland's pain
  • Abstracts: Clutter control. A plan for all seasons. Click and save
  • Abstracts: Attacks could boost telecommunications industry. Japan car shares downshift. Air-flight jitters may boost video-conferencing services
  • Abstracts: Asean gets a lift from new leaders before summit. Japan's late play for Asean
This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.
Some parts © 2025 Advameg, Inc.